Hepatitis A vaccination in chronic carriers of hepatitis B virus

J Pediatr. 1999 Jun;134(6):784-5. doi: 10.1016/s0022-3476(99)70300-8.

Abstract

Because hepatitis A infection may be more severe in patients with chronic liver disease, we vaccinated 33 children who were chronic HBsAg carriers against hepatitis A virus. Anti-hepatitis A virus seroconversion rates after the first, second, and third doses were 90.9%, 96.9%, and 100%, respectively.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Carrier State
  • Child
  • Child, Preschool
  • Female
  • Hepatitis A / immunology
  • Hepatitis A / prevention & control*
  • Hepatitis A Vaccines
  • Hepatitis B Surface Antigens / analysis*
  • Hepatitis B virus / immunology*
  • Hepatitis B, Chronic / immunology*
  • Humans
  • Male
  • Vaccination
  • Viral Hepatitis Vaccines / administration & dosage*
  • Viral Hepatitis Vaccines / immunology

Substances

  • Hepatitis A Vaccines
  • Hepatitis B Surface Antigens
  • Viral Hepatitis Vaccines